ORIC Pharmaceuticals Presents Preclinical Data To Support The Potential Of Oric-944 As A Best-In-Class PRC2 Inhibitor For The Treatment Of Prostate Cancer

TradingKey - On May 6 (ET), optical component supplier Coherent Corp (COHR) reported fiscal third-quarter results that beat Wall Street estimates for both revenue and earnings per share (EPS). However, the stock plunged over 16% at one point during the following day's trading and ended the session down more than 7%.

TradingKey - According to a Reuters report on May 8, major tech giants are racing to procure memory chips. Some tech companies have reportedly proposed funding the construction of new production lines for SK Hynix or even purchasing expensive lithography equipment for the firm. This development sugg

TradingKey - During the US market opening session on May 7, Tesla (TSLA.US) shares extended their rebound momentum, rising more than 2% at one point to open at $406, returning above the $400 level. On May 5 and 6, the stock touched the $400 mark intraday but closed below that threshold on both days.

With a sold-out HBM pipeline, leadership in G9 NAND technology, and a valuation that has yet to fully account for its 2030 trillion-dollar potential, Micron remains a cornerstone "buy" for any long-term tech portfolio.

TradingKey - On May 5 (ET), Advanced Micro Devices (AMD) released its first-quarter fiscal 2026 financial results after the market close. The company reported revenue of $10.253 billion, up 38% year-over-year, exceeding market expectations of $9.89 billion. Non-GAAP earnings per share (EPS) were $1.